There are 2401 resources available
Breast cancer, early stage: Invited Discussant LBA9, LBA10 and 148O
Presenter: Nadia Harbeck
Session: Breast cancer, early stage
Resources:
Slides
Webcast
Access to anti-cancer medicines: How Germany is tackling the issue
Presenter: Bernhard Woermann
Session: ESMO-ESOP: The growing need for collaboration between clinicians and oncology pharmacists
Resources:
Slides
Webcast
2397 - Primary results of LORELEI: a phase II randomized, double-blind study of neoadjuvant letrozole (LET) plus taselisib versus LET plus placebo (PLA) in postmenopausal patients (pts) with ER+/HER2-negative early breast cancer (EBC)
Presenter: Cristina Saura
Session: Breast cancer, early stage
Resources:
Abstract
Slides
The WHO-ESMO Health Workforce Survey: Preliminary results from Italy
Presenter: Mathieu Boniol
Session: ESMO-WHO: Workforce optimisation: a WHO-ESMO study on health workforce requirements, using the example of breast cancer care
Resources:
Slides
Webcast
WHO-ESMO Health Workforce Survey: What is different in Spain?
Presenter: César Rodriguez
Session: ESMO-WHO: Workforce optimisation: a WHO-ESMO study on health workforce requirements, using the example of breast cancer care
Resources:
Slides
2275 - Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) for resectable esophagogastric cancer: updated results from multicenter, randomized phase 3 FLOT4-AIO trial (German Gastric Group at AIO)
Presenter: Salah-Eddin Al-Batran
Session: Gastrointestinal tumours, non-colorectal 1
Resources:
Abstract
Slides
Webcast
5642 - KEYNOTE-059 Update: Efficacy and Safety of Pembrolizumab Alone or in Combination With Chemotherapy in Patients With Advanced Gastric or Gastroesophageal (G/GEJ) cancer
Presenter: Zev Wainberg
Session: Gastrointestinal tumours, non-colorectal 1
Resources:
Abstract
Slides
Webcast
Genitourinary tumours, prostate: Invited Discussant LBA32
Presenter: Joaquin Mateo
Session: Genitourinary tumours, prostate
Resources:
Slides
Webcast
Combination of drugs acting on the immune system
Presenter: Suzanne Topalian
Session: Immunotherapy: The next steps
Resources:
Slides
Webcast
When to discontinue immunotherapy
Presenter: Caroline Robert
Session: Immunotherapy: The next steps
Resources:
Slides
Webcast